Unilever to acquire men's personal care brand Dr Squatch
Unilever has announced an agreement to buy US-based personal care brand Dr Squatch for an undisclosed sum from growth equity firm Summit Partners. The deal should complete later this year.
The company said the 'complementary acquisition marks another step in expanding Unilever's portfolio towards premium and high-growth spaces'.
The retail and DTC brand is built on 'natural, high-performance personal care products' including natural soaps and body washes, deodorants, hair care, skin care, and other men's grooming products with 'unique scents and quality ingredients'.
And the company was drawn to its 'viral social-first marketing strategies, partnerships with influencers and celebrities, and culturally-relevant collaborations' with limited-edition packs that have 'helped to drive sales and grow a loyal consumer following on social media platforms and beyond'.
Fabian Garcia, president of Unilever Personal Care said: 'Dr Squatch has built a solid foundation and loyal following with highly desirable products and clever digital engagement strategies. Building on its success in the US, we are excited to scale the brand internationally and complement our offering in the fast-growing men's personal care segment.'
And the brand's CEO Josh Friedman added: 'Our mission is to inspire and educate men to be happier and healthier, and we're excited about our ability to amplify our brand and mission in this next chapter with Unilever. We're just getting started... [with] the opportunity to advance the brand's scale, reach new heights internationally, and entertain and positively connect with more consumers seeking high-quality, natural products around the world.'
The brand is distributed through digital commerce, retail and direct-to-consumer channels, primarily in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Network
2 hours ago
- Fashion Network
Glossier CEO Kyle Leahy departs
U.S. cult beauty brand Glossier announced on Tuesday its chief executive officer Kyle Leahy will step down from the top spot by year-end. Leahy took on the CEO role at the New York-based Glossier three years ago, when the executive replaced founder, Emily Weiss, who had helmed her brand since its inception in 2014. A retail veteran, Leahy first joined Glossier in November of 2021, where she served as chief commercial officer, before her promotion to company CEO in May 0f 2022. Prior to that, she spent nine years at American fashion brand Cole Haan serving in varying roles, after cutting her apparel teeth as an analyst at Nike. 'Over three years ago, Emily [Weiss] and I shared exciting news about Glossier's next chapter, and I was honored to step into my role as CEO of the company she built,' Leahy said in note to Glossier employees on Tuesday, as cited by WWD. 'Today, we have reached a new chapter defined by scale, profitability and brand strength. With that foundation in place, the board and I believe this is the right moment to bring in the next CEO to lead this new phase of growth.' Leahy will remain on the Glossier board through 2026, and will assist in finding her successor. Under Leahy, the buzzy cosmetics brand entered Sephora in 2022, across the U.S. and Canada, and recruited Marie Suter as its chief creative director the following year. More recently, Leahy was also instrumental in leading the expansion of Glossier's fragrance business. 'I am so grateful for Kyle's leadership and stewardship of Glossier over these past three-plus years,' said Weiss. "She deeply understands how unique and special this brand is, and was exactly the right person to serve as our CEO as we looked to evolve our business model for sustainability and profitability, and scale our brand. Glossier was always built to be more than just one person — more than me, more than Kyle — and I am excited to partner with her to find our next leader.'
Fashion Network
2 hours ago
- Fashion Network
Glossier CEO Kyle Leahy departs
U.S. cult beauty brand Glossier announced on Tuesday its chief executive officer Kyle Leahy will step down from the top spot by year-end. Leahy took on the CEO role at the New York-based Glossier three years ago, when the executive replaced founder, Emily Weiss, who had helmed her brand since its inception in 2014. A retail veteran, Leahy first joined Glossier in November of 2021, where she served as chief commercial officer, before her promotion to company CEO in May 0f 2022. Prior to that, she spent nine years at American fashion brand Cole Haan serving in varying roles, after cutting her apparel teeth as an analyst at Nike. 'Over three years ago, Emily [Weiss] and I shared exciting news about Glossier's next chapter, and I was honored to step into my role as CEO of the company she built,' Leahy said in note to Glossier employees on Tuesday, as cited by WWD. 'Today, we have reached a new chapter defined by scale, profitability and brand strength. With that foundation in place, the board and I believe this is the right moment to bring in the next CEO to lead this new phase of growth.' Leahy will remain on the Glossier board through 2026, and will assist in finding her successor. Under Leahy, the buzzy cosmetics brand entered Sephora in 2022, across the U.S. and Canada, and recruited Marie Suter as its chief creative director the following year. More recently, Leahy was also instrumental in leading the expansion of Glossier's fragrance business. 'I am so grateful for Kyle's leadership and stewardship of Glossier over these past three-plus years,' said Weiss. "She deeply understands how unique and special this brand is, and was exactly the right person to serve as our CEO as we looked to evolve our business model for sustainability and profitability, and scale our brand. Glossier was always built to be more than just one person — more than me, more than Kyle — and I am excited to partner with her to find our next leader.'
France 24
2 hours ago
- France 24
Child vaccine coverage faltering, threatening millions: study
These trends all increase the threat of future outbreaks of preventable diseases, the researchers said, while sweeping foreign aid cuts threaten previous progress in vaccinating the world's children. A new study published in The Lancet journal looked at childhood vaccination rates across 204 countries and territories. It was not all bad news. An immunisation programme by the World Health Organization was estimated to have saved an estimated 154 million lives over the last 50 years. And vaccination coverage against diseases such as diphtheria, tetanus, whooping cough, measles, polio and tuberculosis doubled between 1980 and 2023, the international team of researchers found. However the gains slowed in the 2010s, when measles vaccinations decreased in around half of the countries, with the largest drop in Latin America. Meanwhile in more than half of all high-income countries there were declines in coverage for at least one vaccine dose. Then the Covid-19 pandemic struck. Routine vaccination services were hugely disrupted during lockdowns and other measures, resulting in nearly 13 million extra children who never received any vaccine dose between 2020 to 2023, the study said. This disparity endured, particularly in poorer countries. In 2023, more than half of the world's 15.7 million completely unvaccinated children lived in just eight countries, the majority in sub-Saharan Africa, according to the study. In the European Union, 10 times more measles cases were recorded last year compared to 2023. In the United States, a measles outbreak surged past 1,000 cases across 30 states last month, which is already more than were recorded in all of 2024. Cases of polio, long eradicated in many areas thanks to vaccination, have been rising in Pakistan and Afghanistan, while Papua New Guinea is currently enduring a polio outbreak. 'Tragedy' "Routine childhood vaccinations are among the most powerful and cost-effective public health interventions available," said senior study author Jonathan Mosser of the US-based Institute for Health Metrics and Evaluation (IHME). "But persistent global inequalities, challenges from the Covid pandemic, and the growth of vaccine misinformation and hesitancy have all contributed to faltering immunisation progress," he said in a statement. In addition, there are "rising numbers of displaced people and growing disparities due to armed conflict, political volatility, economic uncertainty, climate crises," added lead study author Emily Haeuser, also from the IHME. The researchers warned the setbacks could threaten the WHO's goal of having 90 percent of the world's children and adolescents receive essential vaccines by 2030. The WHO also aims to halve the number of children who have received no vaccine doses by 2030 compared to 2019 levels. Just 18 countries have achieved this so far, according to the study, which was funded by the Gates Foundation and the Gavi vaccine alliance. The global health community has also been reeling since President Donald Trump's administration drastically slashed US international aid earlier this year. "For the first time in decades, the number of kids dying around the world will likely go up this year instead of down because of massive cuts to foreign aid," Bill Gates said in a separate statement on Tuesday. "That is a tragedy," the Microsoft co-founder said, committing $1.6 billion to Gavi, which is holding a fund-raising summit in Brussels on Wednesday.
